Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical... see more

Recent & Breaking News (TSXV:VM)

Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors

TheNewsWire April 3, 2024

Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options

TheNewsWire March 26, 2024

Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development

TheNewsWire March 13, 2024

Why carbon-based imaging drug advancement is the future of life sciences

Jocelyn Aspa March 12, 2024

Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement

TheNewsWire March 4, 2024

Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement

TheNewsWire March 1, 2024

Voyageur Pharmaceuticals Ltd. Announces Private Placement

TheNewsWire January 16, 2024

Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors

TheNewsWire December 21, 2023

Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule

TheNewsWire December 21, 2023

Voyageur Pharmaceuticals kickstarts international expansion

Jocelyn Aspa December 14, 2023

Voyageur Pharmaceuticals Initiates International Expansion

TheNewsWire December 14, 2023

Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media

TheNewsWire September 14, 2023

Voyageur Pharmaceuticals Ltd. Announces Filing of Interim Financial Statements, Director Changes and Grant of Stock Options

TheNewsWire August 1, 2023

Voyageur Pharmaceuticals Ltd. Announces DSU Grants

TheNewsWire July 13, 2023

Discovery of a generation: The molecule that can enhance any industry

Jonathon Brown June 28, 2023

Voyageur Pharmaceuticals Publishes White Paper, SmoothX: A Promising New Positive Oral Contrast Agent That Enhances Patient Satisfaction and Diagnostic Excellence in CT Imaging

TheNewsWire June 12, 2023

The Canadian-made ground-breaking radiopharmaceutical breakthrough

Jonathon Brown June 6, 2023

Advancing environmental work at the Frances Creek barium project

Jonathon Brown May 31, 2023

Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work at Frances Creek Project Site For Notice of Work & Quarry Permitting

TheNewsWire May 31, 2023

Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs

TheNewsWire May 24, 2023